ERBB2 and breast carcinoma: The arrival of microarray-based gene expression data led to the division of breast cancers into five intrinsic molecular subtypes: luminal A, luminal B, HER2 overexpression, normal like, and basal like, and they showed notable differences in clinical outcome [8, 9].